Skip to content

A pragmatic randomised controlled trial to assess the clinical effectiveness of 'guided self-help' versus 'waiting list control' in the management of anxiety and depression in primary care. Self-Help in Anxiety and DEpression (SHADE).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33308608
Enrollment
114
Registered
2005-05-16
Start date
2002-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety/depression Mental and Behavioural Disorders Depressive episode

Interventions

Intervention group - use of a written self-help manual and up to 4 brief (15-30 minute) face-to-face facilitation sessions with a graduate assistant psychologist while on waiting list. Waiting list co

Sponsors

National Primary Care Research and Development Centre (NPCRDC) (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients with anxiety/depression referred from primary care to one of three Greater Manchester psychological therapy services and currently with 3+ months remaining on the waiting list.

Exclusion criteria

Exclusion criteria: 1. Under 18 years of age 2. Baseline score <14 on the Beck Depression Inventory (BDI) and <11 on anxiety scale of the Hospital Anxiety and Depression Scale (HADS) 3. Referred for therapy from source other than primary care 4. Less than 3 months remaining on therapy service waiting list 5. Poor proficiency in English (i.e. inability to complete questionnaires or read the self-help manual) 6. Active suicidal thoughts 7. Current substance misuse 8. Organic brain disease 9. Current contact with specialist mental health services

Design outcomes

Primary

MeasureTime frame
The Hospital Anxiety and Depression Scale (HADS) score

Secondary

MeasureTime frame
1. Beck Depression Inventory (BDI) 2. Social Adjustment Scale (SAS) 3. Clinical Outcomes in Routine Evaluation scale (CORE) 4. Patient satisfaction and other self-report measures of the treatment process

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026